208 related articles for article (PubMed ID: 16099105)
1. Evaluation of efficacy of heartworm preventive products at the FDA.
Hampshire VA
Vet Parasitol; 2005 Oct; 133(2-3):191-5. PubMed ID: 16099105
[TBL] [Abstract][Full Text] [Related]
2. Food and Drug Administration monitoring of adverse drug reactions.
Sills JM; Tanner LA; Milstien JB
Am J Hosp Pharm; 1986 Nov; 43(11):2764-70. PubMed ID: 3799612
[TBL] [Abstract][Full Text] [Related]
3. Form for reporting serious adverse events and product problems with human drug and biological products and devices; availability--FDA. Notice.
Fed Regist; 1993 Jun; 58(105):31596-614. PubMed ID: 10171452
[TBL] [Abstract][Full Text] [Related]
4. Surgical stapler-associated fatalities and adverse events reported to the Food and Drug Administration.
Brown SL; Woo EK
J Am Coll Surg; 2004 Sep; 199(3):374-81. PubMed ID: 15325606
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a single milbemycin oxime administration in combination with praziquantel against experimentally induced heartworm (Dirofilaria immitis) infection in cats.
Genchi C; Cody R; Pengo G; Büscher G; Cavalleri D; Bucci V; Junquera P
Vet Parasitol; 2004 Aug; 122(4):287-92. PubMed ID: 15262006
[TBL] [Abstract][Full Text] [Related]
6. A pharmaceutical manufacturer's perspective on reporting adverse drug experiences.
Sullivan JW
Am J Hosp Pharm; 1990 Jun; 47(6):1342-5. PubMed ID: 2368728
[TBL] [Abstract][Full Text] [Related]
7. The role of the FDA in the effort against AIDS.
Young FE
Public Health Rep; 1988; 103(3):242-5. PubMed ID: 3131814
[TBL] [Abstract][Full Text] [Related]
8. Records and reports regulations for radiation emitting electronic products--FDA. Final rule.
Fed Regist; 1995 Sep; 60(181):48374-87. PubMed ID: 10151183
[TBL] [Abstract][Full Text] [Related]
9. Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project.
Ladewski LA; Belknap SM; Nebeker JR; Sartor O; Lyons EA; Kuzel TC; Tallman MS; Raisch DW; Auerbach AR; Schumock GT; Kwaan HC; Bennett CL
J Clin Oncol; 2003 Oct; 21(20):3859-66. PubMed ID: 14551305
[TBL] [Abstract][Full Text] [Related]
10. Facilities strive to comply with new Act. The long-term effects of the Safe Medical Devices Act are still unknown.
Schuster DK; Butler KH
Health Prog; 1993 May; 74(4):53-7. PubMed ID: 10125364
[TBL] [Abstract][Full Text] [Related]
11. Expedited safety reporting requirements for human drug and biological products; correction--FDA. Final rule; correction.
Fed Regist; 1998 Mar; 63(58):14611-2. PubMed ID: 10177754
[TBL] [Abstract][Full Text] [Related]
12. An overview of the FDA publication Approved Drug Products with Therapeutic Equivalence Evaluations.
Knoben JE; Scott GR; Tonelli RJ
Am J Hosp Pharm; 1990 Dec; 47(12):2696-700. PubMed ID: 2278285
[TBL] [Abstract][Full Text] [Related]
13. Automated support for pharmacovigilance: a proposed system.
Bright RA; Nelson RC
Pharmacoepidemiol Drug Saf; 2002 Mar; 11(2):121-5. PubMed ID: 11998536
[TBL] [Abstract][Full Text] [Related]
14. Silicone gel breast implant adverse event reports to the Food and Drug Administration, 1984-1995.
Brown SL; Parmentier CM; Woo EK; Vishnuvajjala RL; Headrick ML
Public Health Rep; 1998; 113(6):535-43. PubMed ID: 9847926
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary thromboembolism and hypertension after thiacetarsamide vs melarsomine dihydrochloride treatment of Dirofilaria immitis infection in dogs.
Rawlings CA; Raynaud JP; Lewis RE; Duncan JR
Am J Vet Res; 1993 Jun; 54(6):920-5. PubMed ID: 8323063
[TBL] [Abstract][Full Text] [Related]
16. Studies found plastic condom unsafe, yet FDA cleared it for market. Food and Drug Administration.
AIDS Alert; 1995 May; 10(5):61-4. PubMed ID: 11362323
[TBL] [Abstract][Full Text] [Related]
17. List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness--FDA. Proposed rule.
Fed Regist; 1998 Oct; 63(195):54082-9. PubMed ID: 10185826
[TBL] [Abstract][Full Text] [Related]
18. MEDWatch: the new FDA medical products reporting program.
Kessler DA
Am J Hosp Pharm; 1993 Jun; 50(6):1151-2. PubMed ID: 8517452
[No Abstract] [Full Text] [Related]
19. MedWatch: the FDA medical products reporting program.
Rheinstein PH
Am Fam Physician; 1993 Sep; 48(4):636-8. PubMed ID: 8379493
[No Abstract] [Full Text] [Related]
20. Postmarketing studies for approved human drug and licensed biological products; status reports. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Oct; 65(210):64607-19. PubMed ID: 11503687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
